National Stock Number
6505-01-425-7573
National Stock Number (NSN) 6505-01-425-7573, or NIIN 014257573, (meningococcal polysaccharide vac) was assigned February 27, 1996 in the Federal Logistics Information System (FLIS). This NIIN is Available for Manual Assignment. This NSN does not replace any other NSNs.
There are 4 manufacturer part numbers associated with this NSN. None of the associated part number(s) are considered obsolete. The manufacturer part numbers were originally supplied by 2 suppliers. Today, 2 suppliers are listed as Active suppliers for this NSN. Of the active suppliers, only one supplier is deemed design controlled or valid supply parts.
This part number has not been procured by the US Government in over 5 years, with the most recent procurement date of Mar 25, 2013. There have been 9 contracts issued for this part number, with 8 awards given. The US Government has only awarded those contracts to one supplier. The last contract numbers awarded were: SPM2DP13F0168, SPM2DP12F0182, SPM2DP12F0182, SPM2DP10F0517, SPM2DP10F0517. The total value of the awarded contracts has been US$ 7,295.15.
Based on a planned procurement review by the Primary Inventory Control Activity (PICA) on Dec 01, 2020, this NSN's acquisition method was noted as: Acquire directly from the actual manufacturer, whether or not the prime contractor is the actual manufacturer. This part is a commercial/non-developmental/off-the-shelf-item. Valid AMCs: 1, 2, 3, 4 and 5.
This NSN is assigned to Item Name Code (INC) 35545. This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product. NSN 6505014257573 does not contain precious metals.
This NSN is associated to Schedule B 3002200000: vaccines for human medicine. The Schedule B End Use is listed as pharmaceutical preparations. NAICS classification category 325414: biological product (except diagnostic) manufacturing.
This information was last updated on Apr 01, 2024.